Sechenov School
Home › Pathology › Lymphoproliferative Disorders

Lymphoproliferative Disorders

For medical students2 min readUpdated 2026-10-10

Lymphoproliferative disorders are a group of neoplasms originating from lymphoid tissue. Their key feature is monoclonality: all pathological cells descend from a single mutated lymphocyte and express identical antigen receptors.

Basis of DivisionHistogenetic principle based on clusters of differentiation (CD).
Main MarkerMonoclonality reliably distinguishes a neoplasm from reactive conditions.
LeukemiasTumor transformation primarily originates in the bone marrow.
LymphomasOriginate outside the bone marrow, but are capable of leukemization.
WHO CriteriaAccount for cell lineage, differentiation, stage, and genetics.

Pathogenesis and Cellular Properties

Lymphoid cells constitute a highly heterogeneous population that varies in immunophenotypic and functional characteristics. The capacity for neoplastic transformation is retained at virtually every stage of cellular differentiation. This accounts for the immense diversity of lymphoproliferative disorder forms.

Properties of malignant lymphoid cells include:

Differential Diagnosis: Clonality

Normally, each lymphocyte acquires a unique antigen receptor. During tumor progression, this specific receptor is repeatedly reproduced across all daughter cells. As a result, a monoclonal population is formed.

Detecting monoclonality is of critical diagnostic importance. This feature allows the pathologist to reliably distinguish true neoplasia from reactive conditions or polyclonal leukemoid reactions.

Primary Localization and Biological Unity

Based on the site of primary origin, tumors are divided into two broad groups:

  1. Lymphoid leukemias — transformation primarily occurs in the bone marrow.
  2. Lymphomas (lymphosarcomas) — primarily have extramedullary localization (lymph nodes, spleen, skin, mucosa-associated lymphoid tissue).

Modern medicine recognizes the concept of biological unity. It proves the relationship between leukemias and lymphomas of the same lineage regardless of where they originated (in the bone marrow or an extranodal site).

For example, acute lymphoblastic leukemia and lymphoblastic lymphoma share histogenetic similarities and common genetic aberrations, although they are not clinically fully identical. The same applies to the pair «chronic B-cell lymphocytic leukemia — small lymphocytic lymphoma». The boundary between them blurs during the leukemic phase, when the lymphoma infiltrates the bone marrow and spills into the blood.

General Characteristics and Classification of Lymphomas

Lymphomas are malignant monoclonal neoplasms derived from transformed cells at various levels of differentiation (before or after contact with the thymus, lymph nodes, or spleen). They can involve any organ containing lymphoid tissue.

The disease often begins in lymph nodes, progressing to involve new groups, the spleen, liver, and bone marrow. Clinically, this manifests as prominent lymphadenopathy and splenomegaly. Without treatment, tumors tend to disseminate and metastasize, carrying an unfavorable prognosis.

Based on cytogenesis, they are classified into:

To verify the diagnosis according to the WHO classification, it is necessary to establish lineage, degree of differentiation, stage of dissemination, and molecular-genetic alterations.

Variants of Hodgkin Lymphoma

Hodgkin lymphoma is classified into several morphological variants:

Frequently asked questions

What genetic translocations are characteristic of follicular lymphoma?

Follicular lymphoma is characterized by the chromosomal translocation t(14;18). In this mutation, a segment of chromosome 18 containing the bcl-2 proto-oncogene is transferred to chromosome 14 near the immunoglobulin heavy chain (IGH) gene locus. This leads to overexpression of the BCL2 protein, which protects tumor cells from apoptosis and sustains malignant growth.

What cells serve as the morphological substrate of Hodgkin lymphoma?

The morphological substrate of Hodgkin lymphoma consists of specific tumor cells derived from germinal center B lymphocytes. The cellular composition of the tumor population includes:

  • Reed-Steinberg cells — large multinucleated blastic cells.
  • Hodgkin cells — mononuclear variants of Reed-Steinberg cells.
  • Lacunar cells — a variant of tumor cells.
  • Mummified cells — a variant of tumor cells.
  • LP cells — lymphocytic-histiocytic cells.

These elements constitute a minority within the affected lymph node, whereas the bulk is formed by a reactive polymorphic cellular microenvironment.

What are the Ann Arbor staging criteria for lymphomas?

The Ann Arbor classification defines four stages of lymphoma dissemination based on the number of involved node regions and their location relative to the diaphragm:

  • Stage I (localized) — involvement of a single lymph node region or a single extranodal site.
  • Stage II (regional) — involvement of two or more lymph node regions on the same side of the diaphragm.
  • Stage III (generalized) — involvement of lymph node regions on both sides of the diaphragm.
  • Stage IV (disseminated) — diffuse or disseminated extranodal involvement beyond the lymphatic system.
What clusters of differentiation (CD) are characteristic of B-cell lymphomas?

B-cell neoplasms feature the following markers:

  • CD19 and CD20 — for follicular lymphoma, Burkitt lymphoma, and diffuse large B-cell lymphomas.
  • CD19, CD20, CD23, and CD5 — for chronic lymphocytic leukemia / small lymphocytic lymphoma.
  • CD138 — for plasma cell neoplasms, including multiple myeloma.
  • CD21 — a specific B-cell marker.
What types of T-cell lymphomas exist?

Nodal and extranodal (primary cutaneous) types of T-cell lymphomas are distinguished. These include:

  • Angioimmunoblastic T-cell lymphoma — a nodal form.
  • Anaplastic large cell lymphoma — a T/null-cell neoplasm with primary systemic presentation.
  • Mycosis fungoides — a primary epidermotropic cutaneous T-cell lymphoma.
  • Sézary syndrome — a leukemic T-cell lymphoma of mature CD4+ T cells.
How to distinguish a neoplastic process in lymphoid tissue from a reactive condition?

The main criterion is clonality. The neoplastic population is always monoclonal (cells carry the same receptor), whereas reactive leukemoid reactions involve the proliferation of polyclonal cells.

How does leukemia fundamentally differ from lymphoma?

By the site of primary origin. Leukemias start in the bone marrow, whereas lymphomas start in extramedullary tissues (lymph nodes, spleen, skin, mucosa).

What is the leukemization of a lymphoma?

It is a process of lymphoma progression in which tumor cells from the primary extramedullary site begin to infiltrate the bone marrow and massively spill into the peripheral blood.

What criteria are needed to establish a diagnosis according to the WHO?

The pathologist must determine the cell lineage, degree of differentiation, stage of disease dissemination, and specific molecular-genetic alterations.

Go deeper

More topics in Pathology

Tumor Invasion and MetastasisTypes of EdemaPutrid InflammationMorphology of Lung CancerHepatocellular CarcinomaSepticopyemia and SyphilisMorphology of Tumor GrowthSepsisSodium, Potassium and Copper Metabolism DisordersProductive InflammationAortic Valve DiseasePneumoconioses and SilicosisPathology →